<DOC>
	<DOC>NCT00651768</DOC>
	<brief_summary>The purpose of this study is to compare the long term safety of Symbicort with budesonide alone, in adolescents and adults with asthma.</brief_summary>
	<brief_title>Titratable Dosing in Moderate to Severe Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Diagnosis of asthma and baseline lung function tests, symptoms and medication use as determined by the protocol Required and received treatment with inhaled corticosteroids within the timeframe and doses specified in the protocol Has required treatment with noninhaled corticosteroids within previous 30 days, has sensitivity to drugs specified in the protocol or requires treatment with a betablocker. Has had cancer within previous 5 years or has a condition that may put the patient at risk in this study.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>asthma</keyword>
	<keyword>adults</keyword>
	<keyword>adolescents</keyword>
	<keyword>safety</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/formoterol</keyword>
	<keyword>budesonide</keyword>
</DOC>